// App-Quantinova.ai

5048 : Association of plasma tumor DNA (ptDNA) with increased risk of venous thromboembolism (VTE) in metastatic castration resistant prostate cancer patients (mCRPC).

Researchers

Presenter

  • Vincenza Conteduca

Principal Investigators

  • Daniel Wetterskog

  • Fabio Ferroni

  • Alice Rossi

  • Alessandro Romanel

  • Giorgia Gurioli

  • Sara Bleve

  • Caterina Gianni

  • Nicole Brighi

  • Giuseppe Schepisi

  • Cristian Lolli

  • Pietro Cortesi

  • Domenico Barone

  • Francesca Demichelis

  • Giovanni Paganelli

  • Himisha Beltran

  • Gerhardt Attard

  • Ugo De Giorgi

Medical Centers

  • Meldola, MA

  • Italy

  • Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

  • Bart's Cancer Institute, London, United Kingdom

  • IRST-IRCCS, Meldola, Italy

  • University of Trento, Trento, Italy

  • Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

  • Department of Oncology, City Hospital, Rimini, Italy

  • Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

  • Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy

  • Scientific Institute of Romagna for the Study and Treatment of Tumors (IRST), UOC Nuclear Medicine, Meldola, Italy

  • Dana-Farber Cancer Institute, Boston, MA

  • Kings College London, London, United Kingdom

Locations

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Oncology (ONC)

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

  • Venous thrombosis

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Enzalutamide

  • CB-7598

Outcome

  • N/A


Study Design

  • Prospective

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A